Suppr超能文献

通过在饮用水中给予二乙基三胺五乙酸锌(ZnDTPA)优化大鼠体内吸入钚和镅的清除。

Optimising the removal of inhaled plutonium and americium from the rat by administration of ZnDTPA in drinking water.

作者信息

Gray S A, Pearce M J, Stradling G N, Wilson I, Hodgson A, Isaacs K R

机构信息

National Radiological Protection Board, Didcot, Oxon, UK.

出版信息

Hum Exp Toxicol. 1995 Nov;14(11):902-8. doi: 10.1177/096032719501401108.

Abstract
  1. The efficacy of ZnDTPA administered in drinking water has been investigated for removing 238Pu and 241Am from the rat after their simultaneous inhalation as nitrates. 2. The continual administration of ZnDTPA 95 mumol kg-1 d-1 over a 21 d interval commencing 1 h after exposure reduced the 238Pu content of the lungs and total body to 2% and 8% of those in untreated animals; the corresponding values for 241Am were 3% and 5%. 3. The continual intakes of 950 mumol kg-1 d-1, intermittent intakes of 3600 mumol kg-1 d-1 and the repeated injection of 30 mumol kg-1 body weight were considered no more effective. 4. All orally administered concentrations of ZnDTPA, commencing 7 d after exposure, reduced the total body contents of 238Pu and 241Am to 17% and 20% of controls by 28 d. 5. Histopathological examination of the kidneys, liver and gastrointestinal tract showed no apparent effects of these treatment protocols. 6. It is concluded that the oral administration of ZnDTPA could be an effective treatment for the removal of inhaled transportable forms of Pu and Am after human exposure.
摘要
  1. 研究了通过饮用水给予二乙撑三胺五乙酸锌(ZnDTPA),以在大鼠同时吸入硝酸盐形式的238钚和241镅后将其从体内清除的效果。2. 在暴露后1小时开始的21天期间,持续给予95微摩尔/千克/天的ZnDTPA,使肺和全身的238钚含量降至未处理动物的2%和8%;241镅的相应值为3%和5%。3. 持续摄入950微摩尔/千克/天、间歇摄入3600微摩尔/千克/天以及重复注射30微摩尔/千克体重被认为效果不佳。4. 暴露7天后开始口服的所有ZnDTPA浓度,到28天时使全身的238钚和241镅含量降至对照组的17%和20%。5. 对肾脏、肝脏和胃肠道的组织病理学检查显示这些治疗方案没有明显影响。6. 得出结论,口服ZnDTPA可能是人体暴露后清除吸入的可迁移形式的钚和镅的有效治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验